MedTrace Logo

Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray

NCT06023368 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2024-11-14

No results posted yet for this study

Summary

The goal of this clinical trial is to compare a sterile vapocoolant spray to EMLA cream in children with access ports.

Participants will receive either the spray or cream prior to port access and rate pain on a scale.

Researchers will compare spray vs cream to see if the spray is as effective as the cream in reducing pain associated with port puncture.

Conditions

  • Pediatric Cancer

Interventions

DRUG

Num Vapocoolant Spray

Spray applied around port prior to access

DRUG

EMLA Cream

cream applied around the port prior to access

Sponsors & Collaborators

  • Bimeco Group

    collaborator UNKNOWN

  • Marianne Hutti

    lead OTHER

Principal Investigators

  • Marianne Hutti, PhD, APRN · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-23
Primary Completion
2024-06-20
Completion
2024-06-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06023368 on ClinicalTrials.gov